DD: Breen plans to sell 89,845 DuPont shares, about $13.2M
Director Edward Breen plans to sell 89,845 DD common shares (~$13.2M) via cashless option exercise, dated 11/05/2026.
What this filing says
Edward Breen, a DuPont officer, filed notice of a proposed sale of 89,845 common shares through Merrill Lynch on the NYSE, with an approximate sale date of 11/05/2026. The shares were acquired through an employee stock option exercise, paid for with a broker-assisted cashless exercise. A Form 144 is a notice of intent to sell, so the sale has not yet been reported as completed.
Key figures
- Shares proposed to be sold
- 89,845 shares
- Aggregate market value
- $13,154,896.25
- Shares outstanding
- 132,532,338 shares
- Approximate sale date
- 11/05/2026
Negative for shareholders
- A senior insider plans to sell shares, which some shareholders may read as a negative signal.
Written by Quantisnow AI from this filing. Not financial advice.
Key terms
- Form 144:
- A notice filed with the SEC before an insider sells restricted or control securities, stating the planned sale size and timing.
- Broker assisted cashless exercise:
- A way to exercise stock options where a broker sells enough of the shares to cover the exercise cost and any taxes, so no cash is paid upfront.
- Rule 10b5-1:
- An SEC rule allowing insiders to set up pre-scheduled trading plans, which can shield sales from claims of trading on private information.
FAQ
How many DuPont shares is Edward Breen planning to sell?
The filing shows a proposed sale of 89,845 common shares, with an aggregate market value of $13,154,896.25.
Where were Edward Breen's shares acquired?
The shares came from the exercise of employee stock options granted by DuPont de Nemours, Inc., dated 11/05/2026.
Historical context for DD
Across the 29 sessions after earlier DD headlines, the stock closed higher 16 times and lower 13 times, with a median move of 1.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | DD | SPY |
|---|---|---|---|
| Nov 3, 2026 | DuPont Reports Third Quarter 2026 Results | +8.6% | +0.3% |
| Oct 29, 2026 | DuPont Net-Zero Climate Targets Validated by Science Based Targets initiative | +1.4% | -0.4% |
| Oct 22, 2026 | DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics | +0.7% | -1.2% |
| Oct 14, 2026 | DuPont Announces Regular Quarterly Dividend on Common Stock | -0.8% | -1.1% |
| Oct 13, 2026 | Barclays initiated coverage on DuPont with a new price target | +0.1% | -0.0% |
| Oct 9, 2026 | DuPont downgraded by Analyst with a new price target | -1.9% | +0.6% |
Keep researching DD
- DD insider tradesEvery buy and sale reported by DuPont de Nemours Inc. officers, directors and large holders.
- DD earnings historyPast DuPont de Nemours Inc. earnings releases, newest first.
- DD financial statementsRevenue, profit, cash flow and balance sheet from DuPont de Nemours Inc.'s SEC filings.
- DD dividend historyDividends DuPont de Nemours Inc. has declared, with ex-dates and payment dates.
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Major Chemicals
- Listed since
- 2017
Follow DD and get a push notification the moment its next story breaks.